Dir_name,Process,PassQC,Model,Condition,Day0,Control,Treatment,CountFile,library_calculation,library_original,ScreenType,otherlnGEO,PMID,Year,Journal,FirstAuthor,Last_Author,Title,Note
Burr_2017_Nature_28813417,Done,N,BxPC-3,PD-L1_High,,,,,,,,,28813417,,,,,,Only ~500 reads match sgRNA sequence.
Burr_2019_CancerCell_31564637,Doing,N,K562,HLA-B_High_Day30,None,unselected_cell,HLA-B_antibody,,,Bassik_human_library.xlsx,CRISPRko,,31564637,2019,cancer cell,Marian L. Burr ,Mark A. Dawson ,An Evolutionarily Conserved Function of Polycomb Silences the MHC Class I Antigen Presentation Pathway and Enables Immune Evasion in Cancer ,
Burr_2019_CancerCell_31564637,Doing,N,K562,panMHCI_High_Day30,None,unselected_cell,HLA-A/B/C_antibody,,,Bassik_human_library.xlsx,CRISPRko,,31564637,2019,cancer cell,Marian L. Burr ,Mark A. Dawson ,An Evolutionarily Conserved Function of Polycomb Silences the MHC Class I Antigen Presentation Pathway and Enables Immune Evasion in Cancer ,
Codina_2019_CellSyst_30797773,Done,N,,,Plasmid,"Cell1,Cell2,Cell3","GW1L.L,GW1L.R,GW1Ld.L,GW1Ld.R,GW1NC.L,GW1NC.R,GW1R.L,GW1R.R,GW1RL.L,GW1RL.R,GW2L.L,GW2L.R,GW2Ld.L,GW2Ld.R,GW2NC.L,GW2NC.R,GW2R.L,GW2R.R,GW2RL.L,GW2RL.R,GW3R.R",count_final_v1.txt,,mGeCKO lib or mBrie lib,CRISPRko,mRNA-seq/scRNA-seq/Phosphoproteomics data,30797773,2019,cell systems,Adan Codina,Sidi Chen,Genome-scale in vivo CRISPR screens identified tumor- intrinsic factors of oncogenesis,
Dong_2019_Cell_31442407,Done,N,E0771-OVA,,None,"Cell1,Cell2,Cell3","m01_Tumor,m02_Tumor,m03_Tumor,m04_Tumor,m05_Tumor",Invivo_normcount.txt,,MKO lib,CRISPRko,mRNA-seq/scRNA-seq,31442407,2019,cell,Matthew B. Dong,Sidi Chen,CRISPR screens in cancer cells co-cultured with different immune cells to identify genes whose knockout influence immune cell killing,
Dong_2019_Cell_31442407,Done,N,E0771-OVA,,None,"Cell1,Cell2,Cell3","m06_Tumor,m07_Tumor,m08_Tumor,m09_Tumor,m10_Tumor",Invivo_normcount.txt,,MKO lib,CRISPRko,mRNA-seq/scRNA-seq,31442407,2019,cell,Matthew B. Dong,Sidi Chen,CRISPR screens in cancer cells co-cultured with different immune cells to identify genes whose knockout influence immune cell killing,
Dong_2019_Cell_31442407,Done,N,E0771-OVA,,None,"Unsorted_D4_1,Unsorted_D4_2,Unsorted_D4_3","Unsort_D7_1,Unsort_D7_2,Unsort_D7_3",Invitro_count.txt,,MKO lib,CRISPRko,mRNA-seq/scRNA-seq,31442407,2019,cell,Matthew B. Dong,Sidi Chen,CRISPR screens in cancer cells co-cultured with different immune cells to identify genes whose knockout influence immune cell killing,
Dong_2019_Cell_31442407,Done,N,E0771-OVA,,None,"Unsorted_D4_1,Unsorted_D4_2,Unsorted_D4_3","Sort_D7_1,Sort_D7_2,Sort_D7_3",Invitro_count.txt,,MKO lib,CRISPRko,mRNA-seq/scRNA-seq,31442407,2019,cell,Matthew B. Dong,Sidi Chen,CRISPR screens in cancer cells co-cultured with different immune cells to identify genes whose knockout influence immune cell killing,
Freeman_2019_CellRep_31509742,Done,Y,B16F10,NK,None,B16F10_NK_ctr,"B16F10_NK_rep1,B16F10_NK_rep2",B16F10_NK.count.txt,library_mBrie.txt,Brie(Doench et al 2016),CRISPRko,,31509742,2019,cell reports,Andrew J. Freeman,Jane Oliaro,identify genes that limit natural killer (NK) cell anti-tumor activity(co-culture),
Freeman_2019_CellRep_31509742,Done,Y,B16F10,MHCI_Low,None,T0_control,MHCI_low,MHCI_low.count.txt,library_mBrie.txt,Brie(Doench et al 2016),CRISPRko,,31509742,2019,cell reports,Andrew J. Freeman,Jane Oliaro,identify genes that limit natural killer (NK) cell anti-tumor activity(co-culture),
Haney_2018_NatGenet_30397336,Done,Y,U937,Midbead,None,"U937_5day_midbead_FT_rep_1,U937_5day_midbead_FT_rep_2","U937_5day_midbead_B_rep_1,U937_5day_midbead_B_rep_2",WG_screen_count.txt,lib_null.txt,"Morgens et al., 2017",CRISPRko,,30397336,2018,nature genetic,Michael S. Haney,Michael C. Bassik,Identification of phagocytosis regulators using magnetic genome-wide CRISPR screens,
Haney_2018_NatGenet_30397336,Done,Y,U937,Smallbead,None,"U937_5day_smallbead_B_rep_1,U937_5day_smallbead_B_rep_2","U937_5day_smallbead_FT_rep_1,U937_5day_smallbead_FT_rep_2",WG_screen_count.txt,lib_null.txt,"Morgens et al., 2017",CRISPRko,,30397336,2018,nature genetic,Michael S. Haney,Michael C. Bassik,Identification of phagocytosis regulators using magnetic genome-wide CRISPR screens,
Haney_2018_NatGenet_30397336,Done,Y,U937,Zymosin,None,"U937_5day_Zymosin_B_rep_1,U937_5day_Zymosin_B_rep_2","U937_5day_Zymosin_FT_rep_1,U937_5day_Zymosin_FT_rep_2",WG_screen_count.txt,lib_null.txt,"Morgens et al., 2017",CRISPRko,,30397336,2018,nature genetic,Michael S. Haney,Michael C. Bassik,Identification of phagocytosis regulators using magnetic genome-wide CRISPR screens,
Haney_2018_NatGenet_30397336,Done,Y,U937,PosBead,None,"U937_5day_PosBead_B_rep_1,U937_5day_PosBead_B_rep_2","U937_5day_PosBead_FT_rep_1,U937_5day_PosBead_FT_rep_2",WG_screen_count.txt,lib_null.txt,"Morgens et al., 2017",CRISPRko,,30397336,2018,nature genetic,Michael S. Haney,Michael C. Bassik,Identification of phagocytosis regulators using magnetic genome-wide CRISPR screens,
Haney_2018_NatGenet_30397336,Done,Y,U937,Myelin,None,"U937_5day_myelin_B_rep_1,U937_5day_myelin_B_rep_2","U937_5day_myelin_FT_rep_1,U937_5day_myelin_FT_rep_2",WG_screen_count.txt,lib_null.txt,"Morgens et al., 2017",CRISPRko,,30397336,2018,nature genetic,Michael S. Haney,Michael C. Bassik,Identification of phagocytosis regulators using magnetic genome-wide CRISPR screens,
Haney_2018_NatGenet_30397336,Done,Y,U937,iggRBC,None,"U937_5day_iggRBC_B_rep_1,U937_5day_iggRBC_B_rep_2","U937_5day_iggRBC_FT_rep_1,U937_5day_iggRBC_FT_rep_2",WG_screen_count.txt,lib_null.txt,"Morgens et al., 2017",CRISPRko,,30397336,2018,nature genetic,Michael S. Haney,Michael C. Bassik,Identification of phagocytosis regulators using magnetic genome-wide CRISPR screens,
Haney_2018_NatGenet_30397336,Done,Y,U937,compRBC,None,"U937_5day_compRBC_B_rep_1,U937_5day_compRBC_B_rep_2","U937_5day_compRBC_FT_rep_1,U937_5day_compRBC_FT_rep_2",WG_screen_count.txt,lib_null.txt,"Morgens et al., 2017",CRISPRko,,30397336,2018,nature genetic,Michael S. Haney,Michael C. Bassik,Identification of phagocytosis regulators using magnetic genome-wide CRISPR screens,
Haney_2018_NatGenet_30397336,Done,Y,U937,Bigbead,None,"U937_5day_bigbead_B_rep_1,U937_5day_bigbead_B_rep_2","U937_5day_bigbead_FT_rep_1,U937_5day_bigbead_FT_rep_2",WG_screen_count.txt,lib_null.txt,"Morgens et al., 2017",CRISPRko,,30397336,2018,nature genetic,Michael S. Haney,Michael C. Bassik,Identification of phagocytosis regulators using magnetic genome-wide CRISPR screens,
Henriksson_2018_Cell_30639098,Done,Y,mNaiveTh,FOXP3,None,s10_FOXP3_neg,s10_FOXP3_pos,grnacnt.txt,lib_null.txt,Self_lib,CRISPRko,CHIP-seq/ATAC-seq/RNA-seq,30639098,2018,Cell,,Sarah A. Teichmann,Genes frequently affect both T helper cell activation and differentiation,
Henriksson_2018_Cell_30639098,Done,Y,mNaiveTh,GATA3,None,sc3_gata3_neg,sc3_gata3_pos,grnacnt.txt,lib_null.txt,Self_lib,CRISPRko,CHIP-seq/ATAC-seq/RNA-seq,30639098,2018,Cell,,Sarah A. Teichmann,Genes frequently affect both T helper cell activation and differentiation,
Henriksson_2018_Cell_30639098,Done,Y,mNaiveTh,GATA3,None,s9_STG_neg,s9_STG_pos,grnacnt.txt,lib_null.txt,Self_lib,CRISPRko,CHIP-seq/ATAC-seq/RNA-seq,30639098,2018,Cell,,Sarah A. Teichmann,Genes frequently affect both T helper cell activation and differentiation,
Henriksson_2018_Cell_30639098,Done,Y,mNaiveTh,IL13,None,sc1_il13_neg,sc1_il13_pos,grnacnt.txt,lib_null.txt,Self_lib,CRISPRko,CHIP-seq/ATAC-seq/RNA-seq,30639098,2018,Cell,,Sarah A. Teichmann,Genes frequently affect both T helper cell activation and differentiation,
Henriksson_2018_Cell_30639098,Done,Y,mNaiveTh,IL13,None,s11_IL13_low,s11_IL13_0,grnacnt.txt,lib_null.txt,Self_lib,CRISPRko,CHIP-seq/ATAC-seq/RNA-seq,30639098,2018,Cell,,Sarah A. Teichmann,Genes frequently affect both T helper cell activation and differentiation,
Henriksson_2018_Cell_30639098,Done,Y,mNaiveTh,IL13,None,s11_IL13_low,s11_IL13_1,grnacnt.txt,lib_null.txt,Self_lib,CRISPRko,CHIP-seq/ATAC-seq/RNA-seq,30639098,2018,Cell,,Sarah A. Teichmann,Genes frequently affect both T helper cell activation and differentiation,
Henriksson_2018_Cell_30639098,Done,Y,mNaiveTh,IL13,None,s11_IL13_low,s11_IL13_2,grnacnt.txt,lib_null.txt,Self_lib,CRISPRko,CHIP-seq/ATAC-seq/RNA-seq,30639098,2018,Cell,,Sarah A. Teichmann,Genes frequently affect both T helper cell activation and differentiation,
Henriksson_2018_Cell_30639098,Done,Y,mNaiveTh,IL13,None,s11_IL13_low,s11_IL13_4,grnacnt.txt,lib_null.txt,Self_lib,CRISPRko,CHIP-seq/ATAC-seq/RNA-seq,30639098,2018,Cell,,Sarah A. Teichmann,Genes frequently affect both T helper cell activation and differentiation,
Henriksson_2018_Cell_30639098,Done,Y,mNaiveTh,IL4,None,s8a_STL_neg,s8a_STL_pos,grnacnt.txt,lib_null.txt,Self_lib,CRISPRko,CHIP-seq/ATAC-seq/RNA-seq,30639098,2018,Cell,,Sarah A. Teichmann,Genes frequently affect both T helper cell activation and differentiation,
Henriksson_2018_Cell_30639098,Done,Y,mNaiveTh,IL4,None,first_il4_neg,first_il4_pos,grnacnt.txt,lib_null.txt,Self_lib,CRISPRko,CHIP-seq/ATAC-seq/RNA-seq,30639098,2018,Cell,,Sarah A. Teichmann,Genes frequently affect both T helper cell activation and differentiation,
Henriksson_2018_Cell_30639098,Done,Y,mNaiveTh,IRF4,None,sc2a_irf4_neg,sc2a_irf4_pos,grnacnt.txt,lib_null.txt,Self_lib,CRISPRko,CHIP-seq/ATAC-seq/RNA-seq,30639098,2018,Cell,,Sarah A. Teichmann,Genes frequently affect both T helper cell activation and differentiation,
Henriksson_2018_Cell_30639098,Done,Y,mNaiveTh,IRF4,None,sx4_IRF4_neg,sx4_IRF4_pos,grnacnt.txt,lib_null.txt,Self_lib,CRISPRko,CHIP-seq/ATAC-seq/RNA-seq,30639098,2018,Cell,,Sarah A. Teichmann,Genes frequently affect both T helper cell activation and differentiation,
Henriksson_2018_Cell_30639098,Done,Y,mNaiveTh,IRF4,None,sx4_IRF4_neg,sx4_IRF4_pos2,grnacnt.txt,lib_null.txt,Self_lib,CRISPRko,CHIP-seq/ATAC-seq/RNA-seq,30639098,2018,Cell,,Sarah A. Teichmann,Genes frequently affect both T helper cell activation and differentiation,
Henriksson_2018_Cell_30639098,Done,Y,mNaiveTh,XBP1,None,sc2b_xbp1_neg,sc2b_xbp1_pos,grnacnt.txt,lib_null.txt,Self_lib,CRISPRko,CHIP-seq/ATAC-seq/RNA-seq,30639098,2018,Cell,,Sarah A. Teichmann,Genes frequently affect both T helper cell activation and differentiation,
Henriksson_2018_Cell_30639098,Done,Y,mNaiveTh,XBP1,None,s8b_XBP1_neg,s8b_XBP1_pos,grnacnt.txt,lib_null.txt,Self_lib,CRISPRko,CHIP-seq/ATAC-seq/RNA-seq,30639098,2018,Cell,,Sarah A. Teichmann,Genes frequently affect both T helper cell activation and differentiation,
Jiang_2019_CellRep_31365872,Done,Y,Daudi_B,CD40,input_rep1_rep2,"low_cd95_cd40L_48h_rep1,low_cd95_cd40L_48h_rep2","high_cd95_cd40L_48h_rep1,high_cd95_cd40L_48h_rep2",Jiang_2019_count.txt,lib_null.txt,Avana lib (Doench et al 2016),CRISPRko,RNA-seq,31365872,2019,cell reports,Chang Jiang,Benjamin E. Gewurz,Genome-wide B cell CRISPR screen reveals factors controlling CD40 levels,
Jiang_2019_CellRep_31365872,Done,Y,Daudi_B,CD40,input_rep3_rep4,"low_cd95_cd40L_48h_rep3,low_cd95_cd40L_48h_rep4","high_cd95_cd40L_48h_rep3,high_cd95_cd40L_48h_rep4",Jiang_2019_count.txt,lib_null.txt,Avana lib (Doench et al 2016),CRISPRko,RNA-seq,31365872,2019,cell reports,Chang Jiang,Benjamin E. Gewurz,Genome-wide B cell CRISPR screen reveals factors controlling CD40 levels,
Kearney_2018_SciImmunol_29776993,Done,Y,MC38,OT-I,T0,IgG,PD1,MC38_screen.count.txt,lib_null.txt,Brie(mouse);Brunello(human),CRISPRko,mRNA-seq,29776993,2018,science immunology,Conor J. Kearney,Jane Oliaro,in vitro and in vivo to identify mechanisms of tumor immune evasion from cytotoxic lymphocytes [CD8+ T cells and natural killer (NK) cells],
Kearney_2018_SciImmunol_29776993,Done,Y,MC38,OT-I,T0,Sup,Sup_tnf,MC38_screen2.count.txt,lib_null.txt,Brie(mouse);Brunello(human),CRISPRko,mRNA-seq,29776993,2018,science immunology,Conor J. Kearney,Jane Oliaro,in vitro and in vivo to identify mechanisms of tumor immune evasion from cytotoxic lymphocytes [CD8+ T cells and natural killer (NK) cells],
Kearney_2018_SciImmunol_29776993,Done,Y,B16F10,OT-I,T0,OT1wt,OT1ko,B16_screen.count.txt,lib_null.txt,Brie(mouse);Brunello(human),CRISPRko,mRNA-seq,29776993,2018,science immunology,Conor J. Kearney,Jane Oliaro,in vitro and in vivo to identify mechanisms of tumor immune evasion from cytotoxic lymphocytes [CD8+ T cells and natural killer (NK) cells],
Liu_2018_NatMed_30559422,Done,Y,HSC4,Dox_shADAR,None,XControl,XTreatment,hsc4_ADAR_suppressor_count.txt,lib_null.txt,,CRISPRko,scRNA-seq/RNA-seq,30559422,2018,nature method,Huayang Liu,E. Robert McDonald III,,
Liu_2018_NatMed_30559422,Done,Y,HSC4,noDox_shADAR,None,X.dT.Control,X.dT.Treatment,hsc4_ADAR_suppressor_count.txt,lib_null.txt,,CRISPRko,scRNA-seq/RNA-seq,30559422,2018,nature method,Huayang Liu,E. Robert McDonald III,,
Manguso_2017_Nature_28723893,Done,Y,B16F10,GVAX_aPD1,None,"B16_Invivo.Input.1,B16_Invivo.Input.2,B16_Invivo.Input.3","B16_Invivo.GVAX_aPD1.1,B16_Invivo.GVAX_aPD1.2,B16_Invivo.GVAX_aPD1.3,B16_Invivo.GVAX_aPD1.4,B16_Invivo.GVAX_aPD1.5,B16_Invivo.GVAX_aPD1.6,B16_Invivo.GVAX_aPD1.7,B16_Invivo.GVAX_aPD1.8,B16_Invivo.GVAX_aPD1.9,B16_Invivo.GVAX_aPD1.10,B16_Invivo.GVAX_aPD1.11,B16_Invivo.GVAX_aPD1.12,B16_Invivo.GVAX_aPD1.13,B16_Invivo.GVAX_aPD1.14,B16_Invivo.GVAX_aPD1.15,B16_Invivo.GVAX_aPD1.16,B16_Invivo.GVAX_aPD1.17,B16_Invivo.GVAX_aPD1.18,B16_Invivo.GVAX_aPD1.19,B16_Invivo.GVAX_aPD1.21,B16_Invivo.GVAX_aPD1.25,B16_Invivo.GVAX_aPD1.26,B16_Invivo.GVAX_aPD1.27,B16_Invivo.GVAX_aPD1.28,B16_Invivo.GVAX_aPD1.29,B16_Invivo.GVAX_aPD1.30",Manguso_2017.pool1.count_normalized.txt,lib_null.txt,Self_lib,CRISPRko,RNA-seq,28723893,2017,Nature,Robert T. Manguso,W. Nicholas Haining,In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target,
Manguso_2017_Nature_28723893,Done,Y,B16F10,GVAX_aPD1,None,"B16_Invivo.Input.1,B16_Invivo.Input.2,B16_Invivo.Input.3,B16_Invivo.Input.4","B16_Invivo.GVAX_aPD1.1,B16_Invivo.GVAX_aPD1.2,B16_Invivo.GVAX_aPD1.3,B16_Invivo.GVAX_aPD1.4,B16_Invivo.GVAX_aPD1.5,B16_Invivo.GVAX_aPD1.6,B16_Invivo.GVAX_aPD1.7,B16_Invivo.GVAX_aPD1.8,B16_Invivo.GVAX_aPD1.9,B16_Invivo.GVAX_aPD1.10,B16_Invivo.GVAX_aPD1.11,B16_Invivo.GVAX_aPD1.12,B16_Invivo.GVAX_aPD1.13,B16_Invivo.GVAX_aPD1.14,B16_Invivo.GVAX_aPD1.15,B16_Invivo.GVAX_aPD1.16,B16_Invivo.GVAX_aPD1.17,B16_Invivo.GVAX_aPD1.18,B16_Invivo.GVAX_aPD1.19,B16_Invivo.GVAX_aPD1.20,B16_Invivo.GVAX_aPD1.21,B16_Invivo.GVAX_aPD1.22,B16_Invivo.GVAX_aPD1.23,B16_Invivo.GVAX_aPD1.24,B16_Invivo.GVAX_aPD1.25,B16_Invivo.GVAX_aPD1.26,B16_Invivo.GVAX_aPD1.27,B16_Invivo.GVAX_aPD1.28,B16_Invivo.GVAX_aPD1.29,B16_Invivo.GVAX_aPD1.30,B16_Invivo.GVAX_aPD1.31",Manguso_2017.pool2.count_normalized.txt,lib_null.txt,Self_lib,CRISPRko,RNA-seq,28723893,2017,Nature,Robert T. Manguso,W. Nicholas Haining,In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target,
Manguso_2017_Nature_28723893,Done,Y,B16F10,GVAX_aPD1,None,"B16_Invivo.Input.1,B16_Invivo.Input.2,B16_Invivo.Input.3","B16_Invivo.GVAX_aPD1.1,B16_Invivo.GVAX_aPD1.2,B16_Invivo.GVAX_aPD1.3,B16_Invivo.GVAX_aPD1.4,B16_Invivo.GVAX_aPD1.5,B16_Invivo.GVAX_aPD1.6,B16_Invivo.GVAX_aPD1.7,B16_Invivo.GVAX_aPD1.8,B16_Invivo.GVAX_aPD1.9,B16_Invivo.GVAX_aPD1.10,B16_Invivo.GVAX_aPD1.11,B16_Invivo.GVAX_aPD1.12,B16_Invivo.GVAX_aPD1.13,B16_Invivo.GVAX_aPD1.14,B16_Invivo.GVAX_aPD1.15,B16_Invivo.GVAX_aPD1.16,B16_Invivo.GVAX_aPD1.17,B16_Invivo.GVAX_aPD1.18,B16_Invivo.GVAX_aPD1.19,B16_Invivo.GVAX_aPD1.20,B16_Invivo.GVAX_aPD1.21,B16_Invivo.GVAX_aPD1.22,B16_Invivo.GVAX_aPD1.23,B16_Invivo.GVAX_aPD1.24,B16_Invivo.GVAX_aPD1.25,B16_Invivo.GVAX_aPD1.26,B16_Invivo.GVAX_aPD1.27,B16_Invivo.GVAX_aPD1.28,B16_Invivo.GVAX_aPD1.29,B16_Invivo.GVAX_aPD1.30,B16_Invivo.GVAX_aPD1.31,B16_Invivo.GVAX_aPD1.32,B16_Invivo.GVAX_aPD1.33",Manguso_2017.pool3.count_normalized.txt,lib_null.txt,Self_lib,CRISPRko,RNA-seq,28723893,2017,Nature,Robert T. Manguso,W. Nicholas Haining,In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target,
Manguso_2017_Nature_28723893,Done,Y,B16F10,GVAX_aPD1,None,"B16_Invivo.Input.1,B16_Invivo.Input.2,B16_Invivo.Input.3","B16_Invivo.GVAX_aPD1.1,B16_Invivo.GVAX_aPD1.2,B16_Invivo.GVAX_aPD1.3,B16_Invivo.GVAX_aPD1.4,B16_Invivo.GVAX_aPD1.5,B16_Invivo.GVAX_aPD1.6,B16_Invivo.GVAX_aPD1.10,B16_Invivo.GVAX_aPD1.11,B16_Invivo.GVAX_aPD1.12,B16_Invivo.GVAX_aPD1.13,B16_Invivo.GVAX_aPD1.14,B16_Invivo.GVAX_aPD1.15,B16_Invivo.GVAX_aPD1.18,B16_Invivo.GVAX_aPD1.20,B16_Invivo.GVAX_aPD1.21,B16_Invivo.GVAX_aPD1.22,B16_Invivo.GVAX_aPD1.23,B16_Invivo.GVAX_aPD1.24,B16_Invivo.GVAX_aPD1.26,B16_Invivo.GVAX_aPD1.28,B16_Invivo.GVAX_aPD1.29,B16_Invivo.GVAX_aPD1.30",Manguso_2017.pool4.count_normalized.txt,lib_null.txt,Self_lib,CRISPRko,RNA-seq,28723893,2017,Nature,Robert T. Manguso,W. Nicholas Haining,In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target,
Manguso_2017_Nature_28723893,Done,Y,B16F10,GVAX,None,"B16_Invivo.Input.1,B16_Invivo.Input.2,B16_Invivo.Input.3","B16_Invivo.GVAX_only.1,B16_Invivo.GVAX_only.2,B16_Invivo.GVAX_only.3,B16_Invivo.GVAX_only.4,B16_Invivo.GVAX_only.5,B16_Invivo.GVAX_only.6,B16_Invivo.GVAX_only.7,B16_Invivo.GVAX_only.8,B16_Invivo.GVAX_only.9,B16_Invivo.GVAX_only.10,B16_Invivo.GVAX_only.11,B16_Invivo.GVAX_only.12,B16_Invivo.GVAX_only.13,B16_Invivo.GVAX_only.14,B16_Invivo.GVAX_only.15,B16_Invivo.GVAX_only.16,B16_Invivo.GVAX_only.17,B16_Invivo.GVAX_only.18,B16_Invivo.GVAX_only.19,B16_Invivo.GVAX_only.20,B16_Invivo.GVAX_only.21,B16_Invivo.GVAX_only.22,B16_Invivo.GVAX_only.23,B16_Invivo.GVAX_only.24,B16_Invivo.GVAX_only.25,B16_Invivo.GVAX_only.26,B16_Invivo.GVAX_only.27,B16_Invivo.GVAX_only.28,B16_Invivo.GVAX_only.29,B16_Invivo.GVAX_only.30",Manguso_2017.pool1.count_normalized.txt,lib_null.txt,Self_lib,CRISPRko,RNA-seq,28723893,2017,Nature,Robert T. Manguso,W. Nicholas Haining,In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target,
Manguso_2017_Nature_28723893,Done,Y,B16F10,GVAX,None,"B16_Invivo.Input.1,B16_Invivo.Input.2,B16_Invivo.Input.3,B16_Invivo.Input.4","B16_Invivo.GVAX_only.1,B16_Invivo.GVAX_only.2,B16_Invivo.GVAX_only.3,B16_Invivo.GVAX_only.4,B16_Invivo.GVAX_only.5,B16_Invivo.GVAX_only.6,B16_Invivo.GVAX_only.7,B16_Invivo.GVAX_only.8,B16_Invivo.GVAX_only.9,B16_Invivo.GVAX_only.10,B16_Invivo.GVAX_only.11,B16_Invivo.GVAX_only.12,B16_Invivo.GVAX_only.13,B16_Invivo.GVAX_only.14,B16_Invivo.GVAX_only.15,B16_Invivo.GVAX_only.16,B16_Invivo.GVAX_only.17,B16_Invivo.GVAX_only.22,B16_Invivo.GVAX_only.23,B16_Invivo.GVAX_only.24,B16_Invivo.GVAX_only.25,B16_Invivo.GVAX_only.26,B16_Invivo.GVAX_only.27,B16_Invivo.GVAX_only.28,B16_Invivo.GVAX_only.29,B16_Invivo.GVAX_only.30,B16_Invivo.GVAX_only.31",Manguso_2017.pool2.count_normalized.txt,lib_null.txt,Self_lib,CRISPRko,RNA-seq,28723893,2017,Nature,Robert T. Manguso,W. Nicholas Haining,In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target,
Manguso_2017_Nature_28723893,Done,Y,B16F10,GVAX,None,"B16_Invivo.Input.1,B16_Invivo.Input.2,B16_Invivo.Input.3","B16_Invivo.GVAX_only.1,B16_Invivo.GVAX_only.2,B16_Invivo.GVAX_only.3,B16_Invivo.GVAX_only.4,B16_Invivo.GVAX_only.5,B16_Invivo.GVAX_only.6,B16_Invivo.GVAX_only.7,B16_Invivo.GVAX_only.8,B16_Invivo.GVAX_only.9,B16_Invivo.GVAX_only.10,B16_Invivo.GVAX_only.11,B16_Invivo.GVAX_only.12,B16_Invivo.GVAX_only.13,B16_Invivo.GVAX_only.14,B16_Invivo.GVAX_only.15,B16_Invivo.GVAX_only.16,B16_Invivo.GVAX_only.17,B16_Invivo.GVAX_only.18,B16_Invivo.GVAX_only.19,B16_Invivo.GVAX_only.20,B16_Invivo.GVAX_only.21,B16_Invivo.GVAX_only.22,B16_Invivo.GVAX_only.23,B16_Invivo.GVAX_only.24,B16_Invivo.GVAX_only.25,B16_Invivo.GVAX_only.26,B16_Invivo.GVAX_only.27,B16_Invivo.GVAX_only.28,B16_Invivo.GVAX_only.29,B16_Invivo.GVAX_only.30",Manguso_2017.pool3.count_normalized.txt,lib_null.txt,Self_lib,CRISPRko,RNA-seq,28723893,2017,Nature,Robert T. Manguso,W. Nicholas Haining,In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target,
Manguso_2017_Nature_28723893,Done,Y,B16F10,GVAX,None,"B16_Invivo.Input.1,B16_Invivo.Input.2,B16_Invivo.Input.3","B16_Invivo.GVAX_only.1,B16_Invivo.GVAX_only.2,B16_Invivo.GVAX_only.3,B16_Invivo.GVAX_only.4,B16_Invivo.GVAX_only.5,B16_Invivo.GVAX_only.6,B16_Invivo.GVAX_only.7,B16_Invivo.GVAX_only.8,B16_Invivo.GVAX_only.9,B16_Invivo.GVAX_only.10,B16_Invivo.GVAX_only.11,B16_Invivo.GVAX_only.12,B16_Invivo.GVAX_only.13,B16_Invivo.GVAX_only.14,B16_Invivo.GVAX_only.15,B16_Invivo.GVAX_only.16,B16_Invivo.GVAX_only.17,B16_Invivo.GVAX_only.18,B16_Invivo.GVAX_only.19,B16_Invivo.GVAX_only.22,B16_Invivo.GVAX_only.23,B16_Invivo.GVAX_only.24,B16_Invivo.GVAX_only.25,B16_Invivo.GVAX_only.26,B16_Invivo.GVAX_only.27,B16_Invivo.GVAX_only.28,B16_Invivo.GVAX_only.29,B16_Invivo.GVAX_only.30",Manguso_2017.pool4.count_normalized.txt,lib_null.txt,Self_lib,CRISPRko,RNA-seq,28723893,2017,Nature,Robert T. Manguso,W. Nicholas Haining,In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target,
Manguso_2017_Nature_28723893,Done,Y,B16F10,TCRa_KO,None,"B16_Invivo.Input.1,B16_Invivo.Input.2,B16_Invivo.Input.3","B16_Invivo.TCRa_KO.1,B16_Invivo.TCRa_KO.2,B16_Invivo.TCRa_KO.3,B16_Invivo.TCRa_KO.4,B16_Invivo.TCRa_KO.5,B16_Invivo.TCRa_KO.6,B16_Invivo.TCRa_KO.7,B16_Invivo.TCRa_KO.8,B16_Invivo.TCRa_KO.9,B16_Invivo.TCRa_KO.10,B16_Invivo.TCRa_KO.11,B16_Invivo.TCRa_KO.12,B16_Invivo.TCRa_KO.13,B16_Invivo.TCRa_KO.14,B16_Invivo.TCRa_KO.15,B16_Invivo.TCRa_KO.16,B16_Invivo.TCRa_KO.17,B16_Invivo.TCRa_KO.18,B16_Invivo.TCRa_KO.19,B16_Invivo.TCRa_KO.20,B16_Invivo.TCRa_KO.21,B16_Invivo.TCRa_KO.28,B16_Invivo.TCRa_KO.29,B16_Invivo.TCRa_KO.30",Manguso_2017.pool1.count_normalized.txt,lib_null.txt,Self_lib,CRISPRko,RNA-seq,28723893,2017,Nature,Robert T. Manguso,W. Nicholas Haining,In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target,
Manguso_2017_Nature_28723893,Done,Y,B16F10,TCRa_KO,None,"B16_Invivo.Input.1,B16_Invivo.Input.2,B16_Invivo.Input.3,B16_Invivo.Input.4"," B16_Invivo.TCRa_KO.1,B16_Invivo.TCRa_KO.2,B16_Invivo.TCRa_KO.3,B16_Invivo.TCRa_KO.4,B16_Invivo.TCRa_KO.5,B16_Invivo.TCRa_KO.6,B16_Invivo.TCRa_KO.7,B16_Invivo.TCRa_KO.8,B16_Invivo.TCRa_KO.9,B16_Invivo.TCRa_KO.10,B16_Invivo.TCRa_KO.11,B16_Invivo.TCRa_KO.12,B16_Invivo.TCRa_KO.13,B16_Invivo.TCRa_KO.14,B16_Invivo.TCRa_KO.15,B16_Invivo.TCRa_KO.16,B16_Invivo.TCRa_KO.17,B16_Invivo.TCRa_KO.18,B16_Invivo.TCRa_KO.19,B16_Invivo.TCRa_KO.20,B16_Invivo.TCRa_KO.21,B16_Invivo.TCRa_KO.22,B16_Invivo.TCRa_KO.23,B16_Invivo.TCRa_KO.24,B16_Invivo.TCRa_KO.25,B16_Invivo.TCRa_KO.26,B16_Invivo.TCRa_KO.27",Manguso_2017.pool2.count_normalized.txt,lib_null.txt,Self_lib,CRISPRko,RNA-seq,28723893,2017,Nature,Robert T. Manguso,W. Nicholas Haining,In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target,
Manguso_2017_Nature_28723893,Done,Y,B16F10,TCRa_KO,None,"B16_Invivo.Input.1,B16_Invivo.Input.2,B16_Invivo.Input.3","B16_Invivo.TCRa_KO.1,B16_Invivo.TCRa_KO.2,B16_Invivo.TCRa_KO.3,B16_Invivo.TCRa_KO.9,B16_Invivo.TCRa_KO.10,B16_Invivo.TCRa_KO.11,B16_Invivo.TCRa_KO.12,B16_Invivo.TCRa_KO.13,B16_Invivo.TCRa_KO.14,B16_Invivo.TCRa_KO.15,B16_Invivo.TCRa_KO.16,B16_Invivo.TCRa_KO.17,B16_Invivo.TCRa_KO.18,B16_Invivo.TCRa_KO.19,B16_Invivo.TCRa_KO.20,B16_Invivo.TCRa_KO.21,B16_Invivo.TCRa_KO.22,B16_Invivo.TCRa_KO.23,B16_Invivo.TCRa_KO.24,B16_Invivo.TCRa_KO.25,B16_Invivo.TCRa_KO.26,B16_Invivo.TCRa_KO.27",Manguso_2017.pool3.count_normalized.txt,lib_null.txt,Self_lib,CRISPRko,RNA-seq,28723893,2017,Nature,Robert T. Manguso,W. Nicholas Haining,In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target,
Manguso_2017_Nature_28723893,Done,Y,B16F10,TCRa_KO,None,"B16_Invivo.Input.1,B16_Invivo.Input.2,B16_Invivo.Input.3","B16_Invivo.TCRa_KO.1,B16_Invivo.TCRa_KO.2,B16_Invivo.TCRa_KO.3,B16_Invivo.TCRa_KO.4,B16_Invivo.TCRa_KO.5,B16_Invivo.TCRa_KO.6,B16_Invivo.TCRa_KO.7,B16_Invivo.TCRa_KO.8,B16_Invivo.TCRa_KO.9,B16_Invivo.TCRa_KO.10,B16_Invivo.TCRa_KO.11,B16_Invivo.TCRa_KO.12,B16_Invivo.TCRa_KO.13,B16_Invivo.TCRa_KO.14,B16_Invivo.TCRa_KO.15,B16_Invivo.TCRa_KO.16,B16_Invivo.TCRa_KO.17,B16_Invivo.TCRa_KO.18,B16_Invivo.TCRa_KO.19,B16_Invivo.TCRa_KO.20,B16_Invivo.TCRa_KO.21,B16_Invivo.TCRa_KO.22,B16_Invivo.TCRa_KO.23,B16_Invivo.TCRa_KO.24,B16_Invivo.TCRa_KO.25,B16_Invivo.TCRa_KO.26,B16_Invivo.TCRa_KO.27,B16_Invivo.TCRa_KO.28,B16_Invivo.TCRa_KO.29,B16_Invivo.TCRa_KO.30",Manguso_2017.pool4.count_normalized.txt,lib_null.txt,Self_lib,CRISPRko,RNA-seq,28723893,2017,Nature,Robert T. Manguso,W. Nicholas Haining,In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target,
Manguso_2017_Nature_28723893,Done,Y,B16F10,In_Vitro,None,"B16_Invivo.Input.1,B16_Invivo.Input.2,B16_Invivo.Input.3","B16_Invivo.In_Vitro.1,B16_Invivo.In_Vitro.2,B16_Invivo.In_Vitro.3",Manguso_2017.pool1.count_normalized.txt,lib_null.txt,Self_lib,CRISPRko,RNA-seq,28723893,2017,Nature,Robert T. Manguso,W. Nicholas Haining,In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target,
Manguso_2017_Nature_28723893,Done,Y,B16F10,In_Vitro,None,"B16_Invivo.Input.1,B16_Invivo.Input.2,B16_Invivo.Input.3,B16_Invivo.Input.4","B16_Invivo.In_Vitro.1,B16_Invivo.In_Vitro.2,B16_Invivo.In_Vitro.3",Manguso_2017.pool2.count_normalized.txt,lib_null.txt,Self_lib,CRISPRko,RNA-seq,28723893,2017,Nature,Robert T. Manguso,W. Nicholas Haining,In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target,
Manguso_2017_Nature_28723893,Done,Y,B16F10,In_Vitro,None,"B16_Invivo.Input.1,B16_Invivo.Input.2,B16_Invivo.Input.3","B16_Invivo.In_Vitro.1,B16_Invivo.In_Vitro.2,B16_Invivo.In_Vitro.3",Manguso_2017.pool3.count_normalized.txt,lib_null.txt,Self_lib,CRISPRko,RNA-seq,28723893,2017,Nature,Robert T. Manguso,W. Nicholas Haining,In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target,
Manguso_2017_Nature_28723893,Done,Y,B16F10,In_Vitro,None,"B16_Invivo.Input.1,B16_Invivo.Input.2,B16_Invivo.Input.3","B16_Invivo.In_Vitro.1,B16_Invivo.In_Vitro.2,B16_Invivo.In_Vitro.3",Manguso_2017.pool4.count_normalized.txt,lib_null.txt,Self_lib,CRISPRko,RNA-seq,28723893,2017,Nature,Robert T. Manguso,W. Nicholas Haining,In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target,
Mezzadra_2017_Nature_28813410,Done,N,HAP1,PDL1,None,HAP1_PDL1_low,HAP1_PDL1_high,,,,CRISPRko,,28813410,2017,Nature,Riccardo Mezzadra,Schumacher TNM,Identification of CMTM6 and CMTM4 as PD-L1 protein regulators,
Mezzadra_2017_Nature_28813410,Done,N,koCMTM6.HAP1,PDL1,None,HAP1_PDL1_CMTM6_KO_low,HAP1_PDL1_CMTM6_KO_high,,,,CRISPRko,,28813410,2017,Nature,Riccardo Mezzadra,Schumacher TNM,Identification of CMTM6 and CMTM4 as PD-L1 protein regulators,
Pan_2018_Science_29301958,Done,Y,B16F10,OT-I,OT-1_input,OT-1_Ctl,OT-1_OVA,Pan_2018_normcount.txt,lib_null.txt,Brie(mouse),CRISPRko,RNA-seq/ ATAC-seq/scRNA,29301958,2018,Science,Deng Pan,Kai W. Wucherpfennig,identify mechanisms of tumor cell resistance to killing by cytotoxic T cells,
Pan_2018_Science_29301958,Done,Y,B16F10,Pmel-1_noIFNg,Pmel-1_Input_IFNg-,Pmel-1_OT1_Ctrl_IFNg-,Pmel-1_IFNg-,Pan_2018_normcount.txt,lib_null.txt,Brie(mouse),CRISPRko,RNA-seq/ ATAC-seq/scRNA,29301958,2018,Science,Deng Pan,Kai W. Wucherpfennig,identify mechanisms of tumor cell resistance to killing by cytotoxic T cells,
Pan_2018_Science_29301958,Done,Y,B16F10,Pmel-1_IFNg,Pmel-1_Input_IFNg,Pmel-1_OT1_Ctrl_IFNg,Pmel-1_IFNg,Pan_2018_normcount.txt,lib_null.txt,Brie(mouse),CRISPRko,RNA-seq/ ATAC-seq/scRNA,29301958,2018,Science,Deng Pan,Kai W. Wucherpfennig,identify mechanisms of tumor cell resistance to killing by cytotoxic T cells,
Parnas_2015_Cell_26189680,Done,Y,BMDCs,TNF,"Pre_LPS_EX1_Sample_1,Pre_LPS_EX1_Sample_2,Pre_LPS_EX1_Sample_3,Pre_LPS_EX1_Sample_4",Low_TNF_EX1,High_TNF_EX1,LPS_TNF_EX1.count.txt,lib_null.txt,GeCKOv2(mouse),CRISPRko,RNA-seq,26189680,2015,Cell,Oren Parnas,Aviv Regev,dozens of known and novel regulators of the LPS response,
Parnas_2015_Cell_26189680,Done,Y,BMDCs,TNF,"Pre_LPS_EX2_Sample_1,Pre_LPS_EX2_Sample_2",Low_TNF_EX2,High_TNF_EX2,LPS_TNF_EX2.count.txt,lib_null.txt,GeCKOv2(mouse),CRISPRko,RNA-seq,26189680,2015,Cell,Oren Parnas,Aviv Regev,dozens of known and novel regulators of the LPS response,
Parnas_2015_Cell_26189680,Done,Y,BMDCs,TNF,"Pre_LPS_EX3_Sample_1,Pre_LPS_EX3_Sample_2",Low_TNF_EX3,High_TNF_EX3,LPS_TNF_EX3.count.txt,lib_null.txt,GeCKOv2(mouse),CRISPRko,RNA-seq,26189680,2015,Cell,Oren Parnas,Aviv Regev,dozens of known and novel regulators of the LPS response,
Patel_2017_Nature_28783722,Done,Y,Mel624,EffectT,Screen1_ETP,Screen1_0p5_NoT,Screen1_0p5_T,2CT_screens_normcountTable.txt,lib_null.txt,GeCKOv.2,CRISPRko,,28783722,2017,Nature,shashank J. Patel,Nicholas P. Restifo,Identification of essential genes for cancer immunotherapy,
Patel_2017_Nature_28783722,Done,Y,Mel624,EffectT,Screen2_ETP,Screen2_0p3_NoT,Screen2_0p3_T,2CT_screens_normcountTable.txt,lib_null.txt,GeCKOv.2,CRISPRko,,28783722,2017,Nature,shashank J. Patel,Nicholas P. Restifo,Identification of essential genes for cancer immunotherapy,
Pech_2019_Elife_31452512,Done,Y,K562,NK-92,None,K562.dropout.day7,NK.1to1,elife_47362_count.txt,lib_null.txt,Avana lib(mRNA) + Gecko v2.0 lib(miRNA),CRISPRko,RNA-seq,31452512,2019,eLife,Matthew F Pech,Jeffrey Settleman,CRISPR screens in cancer cells co-cultured with different immune cells to identify genes whose knockout influence immune cell killing,
Pech_2019_Elife_31452512,Done,Y,K562,NK-92,None,K562.dropout.day7,NK.2.5to1,elife_47362_count.txt,lib_null.txt,Avana lib(mRNA) + Gecko v2.0 lib(miRNA),CRISPRko,RNA-seq,31452512,2019,eLife,Matthew F Pech,Jeffrey Settleman,CRISPR screens in cancer cells co-cultured with different immune cells to identify genes whose knockout influence immune cell killing,
Pech_2019_Elife_31452512,Done,Y,K562,MHCI,None,MHC_sort1_bottom20,MHC_sort1_top20,elife_47362_count_2.txt,lib_null.txt,Avana lib(mRNA) + Gecko v2.0 lib(miRNA),CRISPRko,RNA-seq,31452512,2019,eLife,Matthew F Pech,Jeffrey Settleman,CRISPR screens in cancer cells co-cultured with different immune cells to identify genes whose knockout influence immune cell killing,
Pech_2019_Elife_31452512,Done,Y,K562,MHCI,None,MHC_sort2_bottom20,MHC_sort2_top20,elife_47362_count_2.txt,lib_null.txt,Avana lib(mRNA) + Gecko v2.0 lib(miRNA),CRISPRko,RNA-seq,31452512,2019,eLife,Matthew F Pech,Jeffrey Settleman,CRISPR screens in cancer cells co-cultured with different immune cells to identify genes whose knockout influence immune cell killing,
Ritchie_2019_MolecularCell_31126740,Done,Y,U937,cGAMp,None,ctrl1,cGAMP1,Ritchie_count.tsv,lib_null.txt,Bassik_human_lib.tsv,CRISPRko,,31126740,2019,cancer cell,Christopher Ritchie,Mark A. Dawson,SLC19A1 Is an Importer of the Immunotransmitter cGAMP ,
Ritchie_2019_MolecularCell_31126740,Done,Y,U937,cGAMp,None,ctrl2,cGAMP2,Ritchie_count.tsv,lib_null.txt,Bassik_human_lib.tsv,CRISPRko,,31126740,2019,cancer cell,Christopher Ritchie,Mark A. Dawson,SLC19A1 Is an Importer of the Immunotransmitter cGAMP ,
Shifrut_2018_Cell_30449619,Done,Y,hCD8T,Essentiality,None,D1_NonDiv,D1_Div,D1_div_nondiv.count_normalized.txt,lib_null.txt,self_lib,CRISPRko,CROP-seq/RNA-seq,30449619,2018,Cell,Eric Shifrut,Alexander Marson,identified essential T cell receptor signaling components and genes,
Shifrut_2018_Cell_30449619,Done,Y,hCD8T,Essentiality,None,D2_NonDiv,D2_Div,D1_div_nondiv.count_normalized.txt,lib_null.txt,self_lib,CRISPRko,CROP-seq/RNA-seq,30449619,2018,Cell,Eric Shifrut,Alexander Marson,identified essential T cell receptor signaling components and genes,
Vredevoogd_2019_Cell_31303383,Done,Y,IFNGR1mut.SKCM,MART-1,"Library_reference_replicate1,Library_reference_replicate2","Ctrl_Tcells_replicate1,Ctrl_Tcells_replicate2","MART-1_Tcells_replicate1,MART-1_Tcells_replicate2",DavidVredevoogd_rawcount_1.txt,lib_null.txt,GeCKO,CRISPRko,proteomics,31303383,2019,Cell,David W. Vredevoogd,Daniel S. Peeper,CRISPR/Cas9 screen uncovers hits in the TNF pathway that sensitize to T cell attack,
Vredevoogd_2019_Cell_31303383,Done,Y,IFNGR1mut.SKCM,MART-1,"Library_reference_replicate1,Library_reference_replicate2","Ctrl_Tcells_replicate1,Ctrl_Tcells_replicate2","MART-1_Tcells_replicate1,MART-1_Tcells_replicate2",DavidVredevoogd_rawcount_2.txt,lib_null.txt,GeCKO,CRISPRko,proteomics,31303383,2019,Cell,David W. Vredevoogd,Daniel S. Peeper,CRISPR/Cas9 screen uncovers hits in the TNF pathway that sensitize to T cell attack,